4.8 Article

Global Mental Health 2 Child and adolescent mental health worldwide: evidence for action

Journal

LANCET
Volume 378, Issue 9801, Pages 1515-1525

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(11)60827-1

Keywords

-

Funding

  1. Novartis
  2. Shire
  3. Deva
  4. Janssen-Cilag
  5. Abbott
  6. Eli-Lilly
  7. Brazilian Research Council (CNPq)
  8. Wellcome Trust [080534/Z/06/Z]
  9. Wellcome Trust [080534/Z/06/Z] Funding Source: Wellcome Trust

Ask authors/readers for more resources

Mental health problems affect 10-20% of children and adolescents worldwide. Despite their relevance as a leading cause of health-related disability in this age group and their longlasting effects throughout life, the mental health needs of children and adolescents are neglected, especially in low-income and middle-income countries. In this report we review the evidence and the gaps in the published work in terms of prevalence, risk and protective factors, and interventions to prevent and treat childhood and adolescent mental health problems. We also discuss barriers to, and approaches for, the implementation of such strategies in low-resource settings. Action is imperative to reduce the burden of mental health problems in future generations and to allow for the full development of vulnerable children and adolescents worldwide.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available